Literature DB >> 1730492

Comparative immunogenicity of conjugates composed of the Staphylococcus aureus type 8 capsular polysaccharide bound to carrier proteins by adipic acid dihydrazide or N-succinimidyl-3-(2-pyridyldithio)propionate.

A Fattom1, J Shiloach, D Bryla, D Fitzgerald, I Pastan, W W Karakawa, J B Robbins, R Schneerson.   

Abstract

Staphylococcus aureus type 8 capsular polysaccharide (CP) was conjugated either to diphtheria toxoid or to Pseudomonas aeruginosa recombinant exoprotein A by using adipic acid dihydrazide (ADH) or N-succinimidyl-3-(2-pyridyldithio)propionate (SPDP) as the joining reagent. The polysaccharide/protein ratios of these two pairs of conjugates were similar. The two synthetic schemes bound the linker to the carboxyls of the type 8 CP by carbodiimide-mediated condensation. ADH was bound to the carboxyls of the protein, whereas SPDP reacted with the amino groups of the protein. Intermolecular linking of the carrier protein, caused by the carbodiimide during the conjugation reaction with the type 8 CP derivative, probably accounts for the larger size of the conjugates formed with ADH compared with those formed with SPDP. Both conjugates synthesized with ADH elicited higher levels of CP antibodies, especially after the first immunization, than did those prepared with SPDP. Similar levels of exoprotein A antibodies were elicited by both conjugates. Higher levels of diphtheria toxoid antibodies were elicited by the conjugate prepared with SPDP than by the one prepared with ADH. The basis for the differences in the immunogenicities of these two pairs of S. aureus type 8 CP conjugates is discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1730492      PMCID: PMC257668          DOI: 10.1128/iai.60.2.584-589.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.609


  34 in total

1.  The specific direct interaction of helper T cells and antigen-presenting B cells.

Authors:  A Kupfer; S L Swain; C A Janeway; S J Singer
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

2.  Prevalence of capsular polysaccharide types 5 and 8 among Staphylococcus aureus isolates from cow, goat, and ewe milk.

Authors:  B Poutrel; A Boutonnier; L Sutra; J M Fournier
Journal:  J Clin Microbiol       Date:  1988-01       Impact factor: 5.948

3.  Capsular antibodies induce type-specific phagocytosis of capsulated Staphylococcus aureus by human polymorphonuclear leukocytes.

Authors:  W W Karakawa; A Sutton; R Schneerson; A Karpas; W F Vann
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

4.  Bacteremia at Boston City Hospital: Occurrence and mortality during 12 selected years (1935-1972), with special reference to hospital-acquired cases.

Authors:  J E McGowan; M W Barnes; M Finland
Journal:  J Infect Dis       Date:  1975-09       Impact factor: 5.226

5.  Comparative immunogenicities of Vi polysaccharide-protein conjugates composed of cholera toxin or its B subunit as a carrier bound to high- or lower-molecular-weight Vi.

Authors:  S C Szu; X R Li; R Schneerson; J H Vickers; D Bryla; J B Robbins
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

6.  Quantitative and qualitative analyses of serum antibodies elicited in adults by Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-tetanus toxoid conjugates.

Authors:  R Schneerson; J B Robbins; J C Parke; C Bell; J J Schlesselman; A Sutton; Z Wang; G Schiffman; A Karpas; J Shiloach
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

7.  Staphylococcus aureus bacteremia. Current clinical patterns.

Authors:  C M Nolan; H N Beaty
Journal:  Am J Med       Date:  1976-04       Impact factor: 4.965

8.  Protective activity of antibodies to exotoxin A and lipopolysaccharide at the onset of Pseudomonas aeruginosa septicemia in man.

Authors:  M Pollack; L S Young
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

9.  Protein thiolation and reversible protein-protein conjugation. N-Succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagent.

Authors:  J Carlsson; H Drevin; R Axén
Journal:  Biochem J       Date:  1978-09-01       Impact factor: 3.857

10.  Domain II mutants of Pseudomonas exotoxin deficient in translocation.

Authors:  Y Jinno; M Ogata; V K Chaudhary; M C Willingham; S Adhya; D FitzGerald; I Pastan
Journal:  J Biol Chem       Date:  1989-09-25       Impact factor: 5.486

View more
  15 in total

1.  Synthesis and immunological properties of Vi and di-O-acetyl pectin protein conjugates with adipic acid dihydrazide as the linker.

Authors:  Z Kossaczka; S Bystricky; D A Bryla; J Shiloach; J B Robbins; S C Szu
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

2.  Group B Streptococcus capsular polysaccharide-cholera toxin B subunit conjugate vaccines prepared by different methods for intranasal immunization.

Authors:  X Shen; T Lagergård; Y Yang; M Lindblad; M Fredriksson; J Holmgren
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

3.  Comparative immunogenicity of conjugates composed of Escherichia coli O111 O-specific polysaccharide, prepared by treatment with acetic acid or hydrazine, bound to tetanus toxoid by two synthetic schemes.

Authors:  R K Gupta; W Egan; D A Bryla; J B Robbins; S C Szu
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

4.  Construction and characterization of a Pseudomonas aeruginosa mucoid exopolysaccharide-alginate conjugate vaccine.

Authors:  Christian Theilacker; Fadie T Coleman; Simone Mueschenborn; Nicolas Llosa; Martha Grout; Gerald B Pier
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

5.  Antibodies to capsular polysaccharides are not protective against experimental Staphylococcus aureus endocarditis.

Authors:  J Nemeth; J C Lee
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

6.  Antigenic determinants of Staphylococcus aureus type 5 and type 8 capsular polysaccharide vaccines.

Authors:  A I Fattom; J Sarwar; L Basham; S Ennifar; R Naso
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

7.  Comparison of conjugates composed of lipopolysaccharide from Shigella flexneri type 2a detoxified by two methods and bound to tetanus toxoid.

Authors:  V Y Polotsky; J B Robbins; D Bryla; R Schneerson
Journal:  Infect Immun       Date:  1994-01       Impact factor: 3.441

8.  A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge.

Authors:  A I Fattom; J Sarwar; A Ortiz; R Naso
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

9.  Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year-old children in Vietnam.

Authors:  Z Kossaczka; F Y Lin; V A Ho; N T Thuy; P Van Bay; T C Thanh; H B Khiem; D D Trach; A Karpas; S Hunt; D A Bryla; R Schneerson; J B Robbins; S C Szu
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.609

10.  Long-lasting and transmission-blocking activity of antibodies to Plasmodium falciparum elicited in mice by protein conjugates of Pfs25.

Authors:  Joanna Kubler-Kielb; Fathy Majadly; Yimin Wu; David L Narum; Chunyan Guo; Louis H Miller; Joseph Shiloach; John B Robbins; Rachel Schneerson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-26       Impact factor: 12.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.